Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
dietary supplement |
| gptkbp:administeredBy |
intravenous injection
oral supplement |
| gptkbp:alternativeName |
gptkb:SAMe
gptkb:S-adenosyl_methionine gptkb:AdoMet |
| gptkbp:biosynthesized_from |
gptkb:ATP
methionine |
| gptkbp:category |
nutraceutical
amino acid derivative methyl donor |
| gptkbp:chemicalFormula |
C15H22N6O5S
|
| gptkbp:contraindication |
bipolar disorder
antidepressants |
| gptkbp:degradedBy |
gptkb:adenosine
homocysteine |
| gptkbp:discoveredBy |
gptkb:Giulio_Cantoni
|
| gptkbp:discoveredIn |
1952
|
| gptkbp:foundIn |
human body
|
| https://www.w3.org/2000/01/rdf-schema#label |
SAM E
|
| gptkbp:IUPACName |
gptkb:S-adenosyl-L-methionine
|
| gptkbp:regulates |
dietary supplement (US)
prescription drug (Europe) |
| gptkbp:role |
methyl group donor
involved in methylation involved in transsulfuration pathway |
| gptkbp:sideEffect |
anxiety
insomnia gastrointestinal upset |
| gptkbp:usedFor |
gptkb:depression
gptkb:liver_disease osteoarthritis |
| gptkbp:bfsParent |
gptkb:Atmel_SAM_E70
|
| gptkbp:bfsLayer |
6
|